AstraZeneca holds talks with Bristol Myers Squibb on mega-deal, FT reports 

Aug 2 (Reuters) – UK drugmaker AstraZeneca has been exploring a deal to combine with U.S. rival Bristol Myers Squibb , the Financial Times reported on Sunday, citing people familiar with the matter.

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)